Low-Molecular–Weight Heparin versus Unfractionated Heparin in Pregnant Women with Recurrent Abortion associated with Antiphospholipid Syndrome

Role of low molecular weight of heparin in preventing severe preeclampsia

TIMING OF INITIATION OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND ASPIRIN ADMINISTRATION ON THE PREGNANCY OUTCOMES IN WOMEN WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND RECURRENT ABORTI

Prognosis of Unfractioned Heparin versus Low Molecular Weight Heparin in Pumlonary Embolism: Review Article

Effect of Sildenafil Citrate When Added to Low Molecular Weight Heparin and Small Dose Aspirin on Uteroplacental Perfusion in Cases of High-Risk Pregnancy

Combined Low Dose Aspirin and Steroids vs Aspirin Only in Management of Unexplained Recurrent Miscarriage

Effect of Low Dose Aspirin Therapy on Pregnancy Rate in Women Undergoing in vitro Fertilization: A Randomised Controlled Trial

Combined Low Dose Aspirin and 17 α Hydroxyl Progesterone versus 17 α Hydroxyl Progesterone Alone Study in Pregnancy: A Randomized Clinical Trial for Prevention of Spontaneous Pre

Therapeutic versus Prophylactic Anticoagulation with Low Molecular Weight Heparin for Moderate COVID-19 Patients

Efficacy and Safety of Low-Dose Aspirin and Vaginal Progesterone in the Prevention of Spontaneous Preterm Birth